Description:

A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT02497378

Link:

https://clinicaltrials.gov/show/NCT02497378

Keywords:
Versions (1) ▾
  1. 5/15/19
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

May 15, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT02497378

Eligibility Multiple Myeloma NCT02497378

Inclusion Criteria
Exclusion Criteria